Mo1518 SYMPTOMATIC IMPROVEMENT WITH INTRAVENOUS GUSELKUMAB INDUCTION THERAPY IS OBSERVED EARLY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: POST-HOC ANALYSIS OF QUASAR
Year: 2026
Type: conference-abstract
Source: Gastroenterology
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7160064367
